University of Kentucky Companies

College of Pharmacy

Alkymos Inc.
Robert Yokel 859/257-4855
Alkymos designs, synthesizes and manufactures chelators and chelator-based devices for laboratory, industrial, animal and human applications.

AllTranz
www.alltranz.com
Founded in 2004 by Audra Stinchcomb, pharmacy, the company specializes in transdermal delivery methods of drugs, contracts with pharmaceutical companies and consumer product companies to perform the R&D associated with skin-related toxicity testing and transdermal/topical product development.

Artemetrx
www.artemetrx.com
Artemetrx is a healthcare cost containment company that uses data to develop and implement blueprints for health cost savings. Through its secure, web-based, data analysis tool, Artemetrx integrates medical and prescription claims data into a comprehensive real-time analysis of healthcare utilization, outcomes and expenditures.

Emagin Therapeutics
Develops new and improved drug entities to treat acute, chronic and cancer-related pain and delivery systems for pain management. Based on research by Joe Holtman MD, anethesiology & pain management, and Peter Crooks, pharmaceutical sciences.

Four Tigers LLC
www.four-tigers.com
Four Tigers, founded by Paige Shumate Short and researchers from the University of Kentucky, is developing a pipeline of blackberry-based health products that will be marketed as cosmetics, dietary supplements, and foods. Initial products include a topical vanishing blackberry cream, a blackberry oral capsule targeted to the intestines and colon, and a blackberry chewing gum. Four Tigers is also developing an exciting portfolio of medical products harnessing the potent anti-inflammatory and anti-oxidant properties of blackberries. Utilizing blackberries grown at WindStone Farms, researchers at the University of Kentucky have shown that an extract of the blackberries is able to inhibit the growth of human cancer cells in the laboratory. Studies are under way to explore new medical applications, including studies in animals to demonstrate that blackberry extracts can prevent or treat cancer and inflammatory diseases.

InfraReDx
www.infraredx.com

Insys Therapeutics
www.insystherapeutics.com

Intranasal Therapeutics
www.intranasal.com
Intranasal Therapeutics is a research, development and manufacturing company focused on nasal delivery technology, formulations and devices to administer medications to the systemic blood circulation.

Prescient Medical Inc.
www.prescientmedical.com
Prescient Medical was founded to commercialize pioneering products for the prevention of heart attacks. Prescient is developing new diagnostic techniques and treatments to match the more comprehensive understanding of arterial pathophysiology defined by the cardiology community. Their robust product development portfolio includes both diagnostic and therapeutic catheter-based devices that will allow interventional cardiologists to more precisely tailor focal treatment according to the unique needs of each patient. Based on the research of Robert Lodder, pharmacy.

TrackFive Diagnostics Inc.
Penni Black 859/327-4334

Founded in 2009 by Penni Black, pharmaceutical sciences, TrackFive Diagnostics Inc. will develop genomic-based tests to predict how cancer patients will respond to treatment with EGFR inhibitors that are used to treat metastatic colorectal cancer, non-small cell lung cancer, head and neck cancers and pancreatic cancer.

Triboflow Separations LLC
http://triboflow.com 859/259-0011

Developing an innovative technique and sensors to detect in real time the metabolic activity of microbes and cells and their susceptibility to either drug treatments or viral infections. Based on research by John Stencel, Center for Applied Energy Research.

Yaupon Therapeutics Inc.
www.yaupontherapeutics.com
Yaupon Therapeutics, a specialty pharmaceutical company based on research by Linda Dwoskin and Peter Crooks (pharmaceutical sciences), develops small molecule pharmaceuticals licensed from academic laboratories. The researchers have had great success with lobeline, an alkaloid from American Indian tobacco, which in animal models blocks the desire for methamphetamine. In 2005, Yaupon was named Life Sciences Start-up Company of the Year at the Eastern Technology Council’s Annual Enterprise Awards ceremony.